Report of the meeting of the paediatric working group developing an optimized list of paediatric ARV formulations
Interagency Task Team on prevention and treatment of HIV infection in pregnant women, mothers and their children (5 May 2011, Switzerland)
The meeting was held to discuss an optimal paediatric formulary to serve as guidance to national programmes, procurement agencies, funders and manufacturers. The Paediatric Working Group defined the criteria for optimization and then evaluated all available paediatric products against these criteria. This process resulted in three related lists: Optimal products, Limited-use products and Non-essential products.